The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neuroprotective Products-Global Market Insights and Sales Trends 2025
Synopsis
Neuroprotective Products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions.
The global Neuroprotective Products market size is expected to reach US$ 26850 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Neuroprotective Products in various end use industries. The expanding demands from the Alzheimer's disease, Multiple sclerosis and Others,, are propelling Neuroprotective Products market. Cholinesterase inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NMDA receptor antagonists segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Neuroprotective Products market, driven by demand from China, the second largest economy with some signs of stabilising, the Neuroprotective Products market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuroprotective Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuroprotective Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuroprotective Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuroprotective Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuroprotective Products covered in this report include Genervon, NeuroVive Pharmaceutical, Ceregene, BHR Pharma, Neuren Pharmaceuticals, Allon therapeutics and Bionure, etc.
The global Neuroprotective Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genervon
NeuroVive Pharmaceutical
Ceregene
BHR Pharma
Neuren Pharmaceuticals
Allon therapeutics
Bionure
Global Neuroprotective Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroprotective Products market, Segment by Type:
Cholinesterase inhibitors
NMDA receptor antagonists
Others
Global Neuroprotective Products market, by Application
Alzheimer's disease
Multiple sclerosis
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Neuroprotective Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Neuroprotective Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Neuroprotective Products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions.
The global Neuroprotective Products market size is expected to reach US$ 26850 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Neuroprotective Products in various end use industries. The expanding demands from the Alzheimer's disease, Multiple sclerosis and Others,, are propelling Neuroprotective Products market. Cholinesterase inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NMDA receptor antagonists segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Neuroprotective Products market, driven by demand from China, the second largest economy with some signs of stabilising, the Neuroprotective Products market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuroprotective Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuroprotective Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuroprotective Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuroprotective Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuroprotective Products covered in this report include Genervon, NeuroVive Pharmaceutical, Ceregene, BHR Pharma, Neuren Pharmaceuticals, Allon therapeutics and Bionure, etc.
The global Neuroprotective Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genervon
NeuroVive Pharmaceutical
Ceregene
BHR Pharma
Neuren Pharmaceuticals
Allon therapeutics
Bionure
Global Neuroprotective Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroprotective Products market, Segment by Type:
Cholinesterase inhibitors
NMDA receptor antagonists
Others
Global Neuroprotective Products market, by Application
Alzheimer's disease
Multiple sclerosis
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Neuroprotective Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Neuroprotective Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Neuroprotective Products Market Overview
1.1 Neuroprotective Products Product Overview
1.2 Neuroprotective Products Market Segment by Type
1.2.1 Cholinesterase inhibitors
1.2.2 NMDA receptor antagonists
1.2.3 Others
1.3 Global Neuroprotective Products Market Size by Type
1.3.1 Global Neuroprotective Products Market Size Overview by Type (2018-2029)
1.3.2 Global Neuroprotective Products Historic Market Size Review by Type (2018-2023)
1.3.3 Global Neuroprotective Products Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Neuroprotective Products Sales Breakdown by Type (2018-2023)
1.4.2 Europe Neuroprotective Products Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Neuroprotective Products Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Neuroprotective Products Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Neuroprotective Products Sales Breakdown by Type (2018-2023)
2 Global Neuroprotective Products Market Competition by Company
2.1 Global Top Players by Neuroprotective Products Sales (2018-2023)
2.2 Global Top Players by Neuroprotective Products Revenue (2018-2023)
2.3 Global Top Players by Neuroprotective Products Price (2018-2023)
2.4 Global Top Manufacturers Neuroprotective Products Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neuroprotective Products Market Competitive Situation and Trends
2.5.1 Neuroprotective Products Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Neuroprotective Products Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroprotective Products as of 2022)
2.7 Date of Key Manufacturers Enter into Neuroprotective Products Market
2.8 Key Manufacturers Neuroprotective Products Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Neuroprotective Products Status and Outlook by Region
3.1 Global Neuroprotective Products Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Neuroprotective Products Historic Market Size by Region
3.2.1 Global Neuroprotective Products Sales in Volume by Region (2018-2023)
3.2.2 Global Neuroprotective Products Sales in Value by Region (2018-2023)
3.2.3 Global Neuroprotective Products Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Neuroprotective Products Forecasted Market Size by Region
3.3.1 Global Neuroprotective Products Sales in Volume by Region (2024-2029)
3.3.2 Global Neuroprotective Products Sales in Value by Region (2024-2029)
3.3.3 Global Neuroprotective Products Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Neuroprotective Products by Application
4.1 Neuroprotective Products Market Segment by Application
4.1.1 Alzheimer's disease
4.1.2 Multiple sclerosis
4.1.3 Others
4.2 Global Neuroprotective Products Market Size by Application
4.2.1 Global Neuroprotective Products Market Size Overview by Application (2018-2029)
4.2.2 Global Neuroprotective Products Historic Market Size Review by Application (2018-2023)
4.2.3 Global Neuroprotective Products Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Neuroprotective Products Sales Breakdown by Application (2018-2023)
4.3.2 Europe Neuroprotective Products Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Neuroprotective Products Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Neuroprotective Products Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Neuroprotective Products Sales Breakdown by Application (2018-2023)
5 North America Neuroprotective Products by Country
5.1 North America Neuroprotective Products Historic Market Size by Country
5.1.1 North America Neuroprotective Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Neuroprotective Products Sales in Volume by Country (2018-2023)
5.1.3 North America Neuroprotective Products Sales in Value by Country (2018-2023)
5.2 North America Neuroprotective Products Forecasted Market Size by Country
5.2.1 North America Neuroprotective Products Sales in Volume by Country (2024-2029)
5.2.2 North America Neuroprotective Products Sales in Value by Country (2024-2029)
6 Europe Neuroprotective Products by Country
6.1 Europe Neuroprotective Products Historic Market Size by Country
6.1.1 Europe Neuroprotective Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Neuroprotective Products Sales in Volume by Country (2018-2023)
6.1.3 Europe Neuroprotective Products Sales in Value by Country (2018-2023)
6.2 Europe Neuroprotective Products Forecasted Market Size by Country
6.2.1 Europe Neuroprotective Products Sales in Volume by Country (2024-2029)
6.2.2 Europe Neuroprotective Products Sales in Value by Country (2024-2029)
7 Asia-Pacific Neuroprotective Products by Region
7.1 Asia-Pacific Neuroprotective Products Historic Market Size by Region
7.1.1 Asia-Pacific Neuroprotective Products Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Neuroprotective Products Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Neuroprotective Products Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Neuroprotective Products Forecasted Market Size by Region
7.2.1 Asia-Pacific Neuroprotective Products Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Neuroprotective Products Sales in Value by Region (2024-2029)
8 Latin America Neuroprotective Products by Country
8.1 Latin America Neuroprotective Products Historic Market Size by Country
8.1.1 Latin America Neuroprotective Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Neuroprotective Products Sales in Volume by Country (2018-2023)
8.1.3 Latin America Neuroprotective Products Sales in Value by Country (2018-2023)
8.2 Latin America Neuroprotective Products Forecasted Market Size by Country
8.2.1 Latin America Neuroprotective Products Sales in Volume by Country (2024-2029)
8.2.2 Latin America Neuroprotective Products Sales in Value by Country (2024-2029)
9 Middle East and Africa Neuroprotective Products by Country
9.1 Middle East and Africa Neuroprotective Products Historic Market Size by Country
9.1.1 Middle East and Africa Neuroprotective Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Neuroprotective Products Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Neuroprotective Products Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Neuroprotective Products Forecasted Market Size by Country
9.2.1 Middle East and Africa Neuroprotective Products Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Neuroprotective Products Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Genervon
10.1.1 Genervon Company Information
10.1.2 Genervon Introduction and Business Overview
10.1.3 Genervon Neuroprotective Products Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Genervon Neuroprotective Products Products Offered
10.1.5 Genervon Recent Development
10.2 NeuroVive Pharmaceutical
10.2.1 NeuroVive Pharmaceutical Company Information
10.2.2 NeuroVive Pharmaceutical Introduction and Business Overview
10.2.3 NeuroVive Pharmaceutical Neuroprotective Products Sales, Revenue and Gross Margin (2018-2023)
10.2.4 NeuroVive Pharmaceutical Neuroprotective Products Products Offered
10.2.5 NeuroVive Pharmaceutical Recent Development
10.3 Ceregene
10.3.1 Ceregene Company Information
10.3.2 Ceregene Introduction and Business Overview
10.3.3 Ceregene Neuroprotective Products Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ceregene Neuroprotective Products Products Offered
10.3.5 Ceregene Recent Development
10.4 BHR Pharma
10.4.1 BHR Pharma Company Information
10.4.2 BHR Pharma Introduction and Business Overview
10.4.3 BHR Pharma Neuroprotective Products Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BHR Pharma Neuroprotective Products Products Offered
10.4.5 BHR Pharma Recent Development
10.5 Neuren Pharmaceuticals
10.5.1 Neuren Pharmaceuticals Company Information
10.5.2 Neuren Pharmaceuticals Introduction and Business Overview
10.5.3 Neuren Pharmaceuticals Neuroprotective Products Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Neuren Pharmaceuticals Neuroprotective Products Products Offered
10.5.5 Neuren Pharmaceuticals Recent Development
10.6 Allon therapeutics
10.6.1 Allon therapeutics Company Information
10.6.2 Allon therapeutics Introduction and Business Overview
10.6.3 Allon therapeutics Neuroprotective Products Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Allon therapeutics Neuroprotective Products Products Offered
10.6.5 Allon therapeutics Recent Development
10.7 Bionure
10.7.1 Bionure Company Information
10.7.2 Bionure Introduction and Business Overview
10.7.3 Bionure Neuroprotective Products Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bionure Neuroprotective Products Products Offered
10.7.5 Bionure Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Neuroprotective Products Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Neuroprotective Products Industrial Chain Analysis
11.4 Neuroprotective Products Market Dynamics
11.4.1 Neuroprotective Products Industry Trends
11.4.2 Neuroprotective Products Market Drivers
11.4.3 Neuroprotective Products Market Challenges
11.4.4 Neuroprotective Products Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Neuroprotective Products Distributors
12.3 Neuroprotective Products Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
